Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere
CardioVascular and Interventional Radiology · 2024
DOI: 10.1007/s00270-024-03726-9 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift CardioVascular and Interventional Radiology, 2024. Verfasst von Gyoung Min Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Microspheres, Embolization, Therapeutic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To compare the treatment outcomes of glass and resin microspheres for the treatment of hepatocellular carcinoma (HCC) and evaluate the prognostic factors that influence the outcomes. MATERIALS AND METHODS: We retrospectively reviewed 251 consecutive patients who underwent radioembolization for the treatment of HCC at a single tertiary center. Imaging responses after radioembolization were evaluated using the modified Response Evaluation Criteria in Solid Tumors (mRECIST) 1.1. Progression-free survival (PFS) and overall survival (OS) were analyzed using the Kaplan-Meier method. Univariate and multivariate Cox proportional hazard models were used to identify the prognostic factors. RESULTS: A total of 195 patients were included in this study (glass microsphere, n = 75; resin microsphere, n = 120). The complete and objective response rates were 16.0% and 50.7% in the glass microsphere group and 17.5% and 58.3% in the resin microsphere group, respectively. Median PFS was 241 days in the glass microsphere group and 268 days in the resin microsphere group (p = 0.871). Median OS was 29 months in the glass microsphere group and 40 months in the resin microsphere group (p = 0.669). The only significant prognostic factor was bilobar tumor distribution, which favored resin microspheres (p = 0.023). Procedure-related adverse events occurred more frequently in the resin microsphere group (glass, 2.7% vs. resin, 5.0%; p < 0.001). CONCLUSION: Glass and resin microspheres for the treatment of HCC did not show a significant difference in survival, though major adverse events occurred more frequently with the use of resin microspheres.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.
- Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, 50-1, Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea. dyk1025@yuhs.ac.
- Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, 50-1, Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.
Zitieren
APA
Kim, G. M., Kim, D. Y., Won, J. Y., Moon, S., Kim, S. U., & Kim, B. K. (2024). Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-024-03726-9
Vancouver
Kim GM, Kim DY, Won JY, Moon S, Kim SU, Kim BK. Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere. CardioVascular and Interventional Radiology. 2024. doi:10.1007/s00270-024-03726-9
BibTeX
@article{Kim2024,
author = {Kim, Gyoung Min and Kim, Do Young and Won, Jong Yun and Moon, Sungmo and Kim, Seung Up and Kim, Beom Kyung},
title = {Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere},
journal = {CardioVascular and Interventional Radiology},
year = {2024},
doi = {10.1007/s00270-024-03726-9}
}
EUVIMED